359 filings
Page 5 of 18
8-K
r98f0er hz0evgj
30 Mar 23
Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights
4:07pm
8-K
5c6yxkjjl9ktwvl9
8 Mar 23
Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates
4:10pm
8-K
wy8 g96um9e
2 Mar 23
Entry into a Material Definitive Agreement
8:05am
SC 13G/A
m23yc6owbysv
14 Feb 23
AVENUE THERAPEUTICS / CVI Investments ownership change
11:22am
D
hen369j033ayh
14 Feb 23
$242.54 k in options, sold $242.54 k, 1 investor
9:15am
S-8
mmsvjy10u aybic315
10 Feb 23
Registration of securities for employees
4:06pm
8-K
np05qia3t9yo88rl1
10 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
cyu2p4qnoojul3d 1z
3 Feb 23
Departure of Directors or Certain Officers
4:05pm
8-K
5n4 kxa064c
1 Feb 23
Avenue Therapeutics Announces $3.25 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
8:15am
424B5
rp0tc tld
31 Jan 23
Prospectus supplement for primary offering
12:05pm
8-K
yhixty ncpx
25 Jan 23
Changes in Registrant's Certifying Accountant
4:10pm
DEFA14A
uvn tme1s3b93ks3o0v
17 Jan 23
Additional proxy soliciting materials
9:00am
SC 13D/A
fvt jthufth5
6 Jan 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:31pm
4
k5hocz15
4 Jan 23
Change in insider ownership
5:49pm
DEFA14A
gv6qf4ofxye
4 Jan 23
Additional proxy soliciting materials
11:01am
SC 13G
fted6
4 Jan 23
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
8:25am
SC 13G/A
tobz2zva2gwkee7z
14 Dec 22
AVENUE THERAPEUTICS / Nantahala Capital Management ownership change
4:06pm
DEFA14A
kza561i 2ro
18 Nov 22
Additional proxy soliciting materials
4:30pm